Role of SEP15 Gene Polymorphisms in the Time of Progression to AIDS

Genetic Testing and Molecular Biomarkers

Volumn 20, Issue 7, 2016, Pages 383-387

  Benelli, Jéssica Louise ^a   De Medeiros, Rúbia Marília ^b,c   Matte, Maria Cristina Cotta ^b,c   De Melo, Marineide Gonçalves ^d   De Matos Almeida, Sabrina Esteves ^b   Fiegenbaum, Marilu ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b Technological and Scientific Development Center CDCT   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Nossa Senhora da Conceição Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DNA; SELENOPROTEIN; SELENOPROTEIN 15; UNCLASSIFIED DRUG; SEP15 PROTEIN, HUMAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BRAZIL; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BRAZIL; DISEASE PROGRESSION; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SELENOPROTEINS;

EID: 84978829259     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2015.0206     Document Type: Article

References (25)

1. Baum MK, Campa A, Lai S, et al. (2013) Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: A randomized clinical trial. JAMA 310:2154-2163.
2. Bogden JD, Oleske JM (2007) The essential trace minerals, immunity, and progression of HIV-1 infection. Nutr Res 27: 69-77.
3. Bunupuradah T, Ubolyam S, Hansudewechakul R, et al. (2012) Correlation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptoms. Eur J Clin Nutr 66:900-905.
4. Chandrasekha A, Gupta A (2011) Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: Can good nutrition delay time to HAART and affect response to HAART? Am J Clin Nutr 94:1703S-1715S.
5. Chies JAB, Hutz MH (2003) High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia. Braz J Med Biol Res 36:71-75.
6. da Rocha TJ, Korb C, Schuch JB, et al. (2014) SLC30A3 and SEP15 gene polymorphisms influence the serum concentrations of zinc and selenium in mature adults. Nutr Res 34:742-748.
7. Geybels MS, Hutter CM, Kwon EM, et al. (2013) Variation in selenoenzyme genes and prostate cancer risk and survival. Prostate 73:734-742.
8. Hoffmann FW, Hashimoto AC, Shafer LA, et al. (2010) Dietary selenium modulates activation and differentiation of CD4+ T cells in mice through a mechanism involving cellular free thiols. J Nutr 140:1155-1161.
9. Hu YJ, Korotkov KV, Mehta R, et al. (2001) Distribution and functional consequences of nucleotide polymorphisms in the 3'-untranslated region of the human Sep15 gene. Cancer Res 61:2307-2310.
10. Huang Z, Rose AH, Hoffmann PR (2012) The role of selenium in inflammation and immunity: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 16:705-743.
11. Hurwitz BE, Klaus JR, Llabre MM, et al. (2007) Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: A randomized controlled trial. Arch Intern Med 167:148-154.
12. Jablonska E, Gromadzinska J, Sobala W, et al. (2008) Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr 47: 47-54.
13. Kamwesiga J, Mutabazi V, Kayumba J, et al. (2015) Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: A randomized controlled trial. AIDS 29:1045-1052.
14. Kupka R, Msamanga GI, Spiegelman D, et al. (2004) Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr 134:2556-2560.
15. Lahiri DK, Nurnberg JL (1991) A rapid non-enzimatic method for preparation of HMW DNA from blood for RFPL studies. Nucleic Acids Res 19:5444.
16. National Programme for STD and AIDS. AIDS Epidemic Update, 2010. Ministry of Health, Brazil, 2012, VIII, n1.
17. Penney KL, Schumacher FR, Li H, et al. (2010) A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila) 3:604-610.
18. Pitney CL, Royal M, Klebert M (2009) Selenium supplementation in HIV-infected patients: Is there any potential clinical benefit? J Assoc Nurses AIDS Care 20:326-333.
19. Reshi ML, Su YC, Hong JR (2014) RNA viruses: ROSmediated cell death. Int J Cell Biol 2014:467452.
20. Schrauzer GN, Sacher J (1994) Selenium in the maintenance and therapy of HIV-infected patients. Chem Biol Interact 91:199-205.
21. Singhal N, Austin J (2002) A clinical review of micronutrients in HIV infection. J Int Assoc Physicians AIDS Care (Chic) 1:63-75.
22. Stone CA, Kawai K, Kupka R, et al. (2010) Role of selenium in HIV infection. Nutr Rev 68:671-681.
23. Sutherland A, Kim DH, Relton C, et al. (2010) Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr 5:215-223.
24. Wolbers M, Babiker A, Sabin C, et al. (2010) Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy-The CASCADE collaboration: A collaboration of 23 cohort studies. PLoS Med 7:e1000239.
25. Xu XM, Carlson BA, Grimm TA, et al. (2002) Rhesus monkey simiam immunodeficiency virus infection as a model for assessing the role of selenium in AIDS. J Acquir Immune Defic Syndr 31:453-456.